Reportstack has announced a new market research publication on Torrent Pharmaceuticals Limited - Product Pipeline Review - 2013 which provides data on the Torrent Pharmaceuticals Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from proprietary databases, Torrent Pharmaceuticals Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Torrent Pharmaceuticals Limited and industry-specific third party sources, put together by team of industry experts.
Scope
- Torrent Pharmaceuticals Limited - Brief Torrent Pharmaceuticals Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Torrent Pharmaceuticals Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Torrent Pharmaceuticals Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Torrent Pharmaceuticals Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Torrent Pharmaceuticals Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Torrent Pharmaceuticals Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Torrent Pharmaceuticals Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Torrent Pharmaceuticals Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Torrent Pharmaceuticals Limited and identify potential opportunities in those areas.
This report is built using data and information sourced from proprietary databases, Torrent Pharmaceuticals Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Torrent Pharmaceuticals Limited and industry-specific third party sources, put together by team of industry experts.
Scope
- Torrent Pharmaceuticals Limited - Brief Torrent Pharmaceuticals Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Torrent Pharmaceuticals Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Torrent Pharmaceuticals Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Torrent Pharmaceuticals Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Torrent Pharmaceuticals Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Torrent Pharmaceuticals Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Torrent Pharmaceuticals Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Torrent Pharmaceuticals Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Torrent Pharmaceuticals Limited and identify potential opportunities in those areas.
To view the table of contents and know more details please visit Torrent Pharmaceuticals Limited - Product Pipeline Review - 2013.
No comments:
Post a Comment